Atopic dermatitis

The prevalence of infertility is greater among individuals with AD as compared to healthy individuals without AD. Infertility is the failure to achieve a clinical pregnancy after 12 months or more of unprotected sexual intercourse. A decline in fertility rates is a significant public health concern. Infertility affects approximately 10–15% of couples across the globe....

Individuals with AD are at relatively significant risk for the development of concomitant ED, hence, it is important to remain vigilant of the cutaneous manifestations of ED Atopic dermatitis (AD) is a prevalent inflammatory skin disorder that impairs the quality of life of both the patient and the caregiver to a significant extent. This inflammatory...

Atopic dermatitis is the most prevalent skin disease. Up to 25 percent of children and 8 percent of adults have a current or past atopic dermatitis diagnosis. Atopic dermatitis negatively affects the quality of life and disrupts sleep at night due to itch. In addition to asthma and allergies, atopic dermatitis comorbidities can lead to:...

Racial differences have been observed in the prevalence and presentation of atopic dermatitis in African American and European American patients. African Americans tend to present with extensive papular lesions and widespread extensor surface involvement, as well as lichenification secondary to treatment resistance. Few studies have been conducted on the immune signatures that may drive disease,...

Atopic dermatitis is a common skin condition that severely and negatively affects the quality of life of children and their parents. However, children of Black and Hispanic parents tend to experience persistent and poorly controlled symptoms of atopic dermatitis, which can increase the burden on the quality of life of families of color. In addition,...

Barriers to health care for atopic dermatitis (eczema) and asthma may differ among racial/ethnic minority groups. However, research is limited on the perceptions of these groups regarding access to care. Racial/ethnic minority groups may experience a greater treatment burden and more barriers to appropriate care than other groups. Researchers conducted an online survey across the...

Structural racism involves the policies and practices that have been put in place over time through government and institutions. The physical and social environments where people of African, Latinx, and Indigenous heritage live reflect grave inequities that can influence the risk of developing allergic diseases, including asthma and atopic dermatitis. Physiologic stress responses caused by...

While innate differences between racial/ethnic minority groups and white people with atopic dermatitis may explain certain measures of severity and prevalence, factors concerning racism cannot be ignored. For example, atopic dermatitis disparities occur in Black people, despite genetic risk factors being more prevalent in white people. Although genetic risk factors may be researched more heavily...

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday. The approval is indicated for patients with atopic dermatitis that did not respond to previous treatment and is not well controlled with other medications or when the use...